Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint Dive into the research topics of 'Targeting the PD-1 pathway in patients with relapsed classic Hodgkin lymphoma following allogeneic stem cell transplant is safe and effective'. Together they form a unique fingerprint.

Medicine & Life Sciences